Does Rallies show Form 4 insider transactions for THC?

Yes. Rallies tracks THC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is THC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.

THC (Tenet Healthcare Corporation New) Stock Analysis - Insider Trades

Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of May 20, 2026, THC trades at $185.73 with a market cap of $16.58B and a P/E ratio of 12.05. THC moved -1.88% today. Year to date, THC is -9.47%; over the trailing twelve months it is +11.12%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $248.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading THC stock inside the company?

Recent THC insider activity includes Arbour Paola M sold 6.50K, Arnst Thomas W sold 4.71K, Arnst Thomas W sold 3.29K, Ramsey R. Scott sold 2.13K, and Ramsey R. Scott sold 4.49K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

THC Key Metrics

Key financial metrics for THC
Metric	Value
Price	$185.73
Market Cap	$16.58B
P/E Ratio	12.05
EPS	$15.61
Dividend Yield	0.00%
52-Week High	$247.21
52-Week Low	$109.82
Volume	1.58M
Avg Volume	0
Revenue (TTM)	$21.31B
Net Income	$2.37B
Gross Margin	0.00%

Recent THC Insider Trades

Arbour Paola M sold 6.50K (~$1.55M) on Mar 11, 2026.
Arnst Thomas W sold 4.71K (~$1.12M) on Mar 9, 2026.
Arnst Thomas W sold 3.29K (~$786.87K) on Mar 9, 2026.
Ramsey R. Scott sold 2.13K (~$490.83K) on Mar 2, 2026.
Ramsey R. Scott sold 4.49K (~$1.05M) on Mar 2, 2026.

Latest THC News

Tenet Healthcare jumps as Q1 EPS beat and reaffirmed 2026 outlook drive follow-through bid — May 6, 2026
Tenet Healthcare slips as Q1 revenue miss and softer 2026 sales outlook overshadow EPS beat — May 4, 2026
Tenet Healthcare jumps as Q1 profit beats expectations, USPI strength offsets revenue headwinds — May 1, 2026
Tenet Healthcare slips despite Q1 EPS beat as one-time CommonSpirit boost dominates — Apr 30, 2026
Tenet Reports 73% Net Income Surge to $702M, Free Cash Flow at $978M — Apr 30, 2026

THC Analyst Consensus

15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $248.27.

Common questions about THC

Who is trading THC stock inside the company?: Recent THC insider activity includes Arbour Paola M sold 6.50K, Arnst Thomas W sold 4.71K, Arnst Thomas W sold 3.29K, Ramsey R. Scott sold 2.13K, and Ramsey R. Scott sold 4.49K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for THC?: Yes. Rallies tracks THC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is THC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.